Ironwood Pharmaceuticals (IRWD) Stock Forecast & Price Target
Score
Ironwood Pharmaceuticals, Inc. price target
| IRWD | |
|---|---|
| Low | $3.70 |
| Average | $4.80 |
| High | $5.70 |
| Upside vs current price | -0.6% |
The average target of $4.80 is -0.6% versus the current IRWD price of $4.83.
Ironwood Pharmaceuticals, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 1 |
| Buy | 1 |
| Hold | 2 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
4 analysts cover IRWD.
Ironwood Pharmaceuticals, Inc. EPS and revenue estimates
The estimate table for the Ironwood Pharmaceuticals, Inc. keeps 2027 EPS $1.38, and years with fewer than three analysts are not filled in.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2027 | $1.38 | $515.43M |
Is Ironwood Pharmaceuticals, Inc. a buy or sell?
Of the 4 analysts covering Ironwood Pharmaceuticals, Inc., 2 rate it a buy (1 strong buy and 1 buy), 2 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The IRWD consensus label is Buy, beside 2 buy-side ratings and 0 sell-side ratings.
The average target of $4.80 implies -0.6% versus the current price of $4.83.
the Ironwood Pharmaceuticals, Inc. closes with 2 buy-side ratings and 0 on the sell side. The headcount is Buy.
Reading the Ironwood Pharmaceuticals, Inc. forecast
Analysts are far apart on IRWD. The published low is $3.70, the average is $4.80, and the high is $5.70.
From today's $4.83 print, the IRWD average target is -0.6% away.
Buy and the rest of the scale both have a real share of IRWD: 2 of 4 analysts are on the buy side, 2 are at hold, and 0 are on the sell side, and the published consensus is Buy.
IRWD coverage is thin at 4 analysts, and one revision moves the average.
Ironwood Pharmaceuticals, Inc. forecast questions
What is the IRWD price target?
The published range for IRWD is $3.70 to $5.70, with an average of $4.80. That average is -0.6% versus the current price of $4.83.
Is Ironwood Pharmaceuticals, Inc. a buy or sell?
Of the 4 analysts covering Ironwood Pharmaceuticals, Inc., 2 rate it a buy, 2 rate it a hold, and 0 rate it a sell. The consensus is Buy, which for IRWD is 2 on the buy side, 2 at hold, and 0 on the sell side.
What is the EPS estimate for Ironwood Pharmaceuticals, Inc.?
Analyst EPS estimates for Ironwood Pharmaceuticals, Inc.: 2027 $1.38.
What is the revenue estimate for Ironwood Pharmaceuticals, Inc.?
Analyst revenue estimates for Ironwood Pharmaceuticals, Inc.: 2027 $515.43M.
How many analysts cover IRWD?
4 analysts cover IRWD. Their consensus on IRWD is Buy, across those 4.